# Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging

> **NCT02787356** · NA · WITHDRAWN · sponsor: **SRI International**

## Conditions studied

- Skin Manifestations

## Interventions

- **DRUG:** TDS Lidocaine 5%; generic
- **DRUG:** TDS Lidocaine 5%; RLD

## Key facts

- **NCT ID:** NCT02787356
- **Lead sponsor:** SRI International
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-10-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Project was not funded by FDA
- **Last updated:** 2017-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787356, "Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02787356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*